3TC30mg + AZT60mg Dispersible Tablets is a powerful anti-HIV medication, effective for both adults and children diagnosed with HIV-1. Housing 30mg of Lamivudine (3TC) and 60mg of Zidovudine (AZT), these tablets are prominent for their efficacy in HIV-1 treatment. The dispersible format simplifies preparation, catering to diverse patient needs. The pack contains 60 tablets, which caters to long-term supply and has an impressive shelf life of 24 months. Store the product in its original container below 30°C. Note: No separate chemical formula or CAS number provided for the combination.
Our groundbreaking 3TC30mg + AZT60mg Dispersible Tablets are designed to provide a superior HIV-1 therapy for adults and children. From the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) class, our tablets harness the power of two potent agents, Lamivudine (3TC) and Zidovudine (AZT), for effective management of HIV-1 infection.
The 3TC + AZT Dispersible Tablets are part of the well-respected Nucleoside Reverse Transcriptase Inhibitors (NRTI) class. Noteworthy for its exceptional ability to inhibit the HIV virus' reverse transcriptase enzyme, this class aids in impeding viral replication.
Storage and Usage:
Store in the original container, tightly closed, and away from light, at temperatures below 30u00b0C (86u00b0F). Keep the product away from children's reach. Avoid re-packing and always dispense in original packaging. To administer, disperse tablets in 5ml water.
The product has a generous shelf life of 24 months (2 years), facilitating substantial advance stocking and allowing for uninterrupted treatment pathways.
We provide a range of formulations, pack sizes, and combinations with other Antiretrovirals (ARVs), catering to diverse patient requirements.
Choose the 3TC30mg + AZT60mg Dispersible Tablets for a promising advancement in efficient HIV management.